Depression in Alzheimer's disease: epidemiology, mechanisms, and treatment

Yu-Yuan Huang,Yi-Han Gan,Liu Yang,Wei Cheng,Jin-Tai Yu

DOI: https://doi.org/10.1016/j.biopsych.2023.10.008

IF: 12.81

2023-10-21

Biological Psychiatry

Abstract:Depression and Alzheimer's disease (AD) are substantial public health concerns. In the past decades, a link between two disease entities has received extensive acknowledgment, yet the complex nature of this relationship has demanded further clarification. Some evidence indicates that mid-life depression may be an AD risk factor, while a chronic course of depression in late life may be a precursor to or symptom of dementia. Recently, multiple pathophysiological mechanisms have been proposed to underlie the bidirectional relationship between depression and AD, including genetic predisposition, immune dysregulation, the accumulation of AD-related biomarkers (e.g., amyloid beta and tau), and alterations in brain structure. That being the case, numerous therapeutic approaches, such as pharmacology treatments, psychotherapy, and lifestyle interventions, have been suggested as potential means of interfering with these pathways. However, the current literature on this topic remains fragmented and lacks a comprehensive review characterizing the association between depression and AD. In this review, we aim to address these gaps by providing an overview of the co-occurrence and temporal relationship between depression and AD, as well as exploring their underlying mechanisms. We also examine the current therapeutic regimens for depression and their implications for AD management, and outline key challenges facing the field.

neurosciences,psychiatry